Publication Name	World Journal of Gastroenterology
Manuscript ID	120316
DOI	10.3748/wjg.120316
Country	Türkiye

Category	Gastroenterology & Hepatology
Manuscript Type	Correspondence
Article Title	Reconsidering the routine use of adjuvant somatostatin analogs in type I gastric neuroendocrine tumors after endoscopic treatment
Manuscript Source	Unsolicited Manuscript
All Author List	Bengi Ozturk and Hatime Arzu Yasar
Funding Agency and Grant Number
Corresponding Author	Bengi Ozturk, Assistant Professor, Gastroenterology, Hacettepe University, Hacettepe Mah, Tıp Fakültesi, Hacettepe Üniversitesi, 06230 Altındağ/Ankara, Ankara 06230, Türkiye. drbengiozturk@gmail.com
Key Words	Type I gastric neuroendocrine tumor; Somatostatin analog; Prognosis; Side effects
Core Tip	Type I gastric neuroendocrine tumors are usually indolent and are associated with low metastatic potential. Although adjuvant somatostatin analog therapy following endoscopic resection can reduce recurrence risk, its routine use in low-risk patients should be carefully evaluated considering the scarce survival data and potential treatment-related adverse effects.
Citation	Ozturk B, Yasar HA. Letter to the Editor: Reconsidering the routine use of adjuvant somatostatin analogs in type I gastric neuroendocrine tumors after endoscopic treatment. World J Gastroenterol 2026; In press DOI: https://doi.org/10.3748/wjg.120316
PDF	120316-in-press.pdf

Received	2026-02-25 01:15
Peer-Review Started	2026-02-25 01:15
First Decision by Editorial Office Director	2026-04-15 08:09
Return for Revision	2026-04-15 08:09
Revised	2026-04-26 17:55
Publication Fee Transferred
Second Decision by Editor	2026-06-04 02:54
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-06-04 05:43
Articles in Press	2026-06-04 05:43
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com